Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2016-03-03 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
独立董事关于制定未来三年（2016-2018年）股东分红回报规划的独立意见
Governance Information Classification · 90% confidence The document is an independent director's opinion on the company's future three-year (2016-2018) shareholder dividend return plan. It references relevant laws and regulations regarding cash dividends and shareholder returns. The document is a formal statement of approval and recommendation to submit the dividend plan to the shareholders' meeting. It does not contain financial statements or detailed financial data, nor is it a report or announcement of voting results. It is a governance-related document concerning dividend policy and board decisions. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices, including dividend policies and related board opinions.
2016-03-03 Chinese
募集资金管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '募集资金管理制度' (Fundraising Capital Management System) for a company, outlining the management, storage, usage, supervision, and reporting requirements of funds raised through securities issuance. It references compliance with Chinese laws and Shanghai Stock Exchange rules, and includes procedures for reporting to the exchange and disclosures. The document is a governance and compliance manual related to capital management rather than a financial report, earnings release, or announcement. It does not contain financial statements or results, nor is it a brief announcement or presentation. It fits best under Governance Information (CGR) as it details internal rules and governance practices regarding fundraising capital management.
2016-03-03 Chinese
非公开发行A股股票预案
Capital/Financing Update Classification · 95% confidence The document is titled as a "非公开发行A股股票预案" which translates to "Non-public Issuance of A Shares Stock Proposal". It is a detailed plan and proposal document related to a non-public offering of shares by Zhongyuan Union Cell and Gene Engineering Corp., Ltd. The text includes detailed information about the issuance plan, pricing, number of shares, use of proceeds, background, purpose, and regulatory approvals required. It also discusses the acquisition of a target company (柯莱逊) using the proceeds from the issuance. The document is comprehensive and contains substantive financial and business information related to the capital raising activity. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. It is not an announcement of a report publication, nor is it a full annual or interim report. It is not a proxy statement or voting results announcement. Therefore, the appropriate classification is CAP with high confidence.
2016-03-03 Chinese
关于非公开发行股票预案披露时尚无法提供相关审计报告、评估报告和前次募集资金使用情况报告的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (542 characters) from a company about the status of its non-public stock issuance plan. It states that the related audit report, evaluation report, and previous fundraising usage report are not yet available and will be disclosed later. There is no actual financial data or detailed report content here, only a notice about the delay and future disclosure. According to the 'Menu vs Meal' rule, this is an announcement about a report, not the report itself. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2016-03-03 Chinese
复牌公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the resumption of trading (复牌公告) of the company's stock after a suspension due to planning a non-public stock issuance. It references prior announcements about the suspension and the board's approval of the private placement plan. The content focuses on stock trading status and regulatory compliance related to the stock market listing rules. It does not contain financial statements, detailed financial data, or management discussion. The document is under 5,000 characters and serves as an official notice about stock trading status related to capital raising activities. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to financing activities and stock issuance planning.
2016-03-03 Chinese
第八届监事会第十二次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of resolutions passed by the Supervisory Board regarding a non-public issuance of A shares, including approval of the issuance conditions, pricing, quantity, use of proceeds, and related agreements. It includes voting results and mentions that these resolutions require shareholder meeting approval. The content focuses on capital raising activities and share issuance plans, with detailed terms and conditions. It is not a full financial report, audit, or earnings release, but rather a formal announcement of financing plans and related board decisions. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is under 5,000 characters but contains substantive details of the financing plan, not just a brief announcement or report publication notice, so it is not RPA or RNS.
2016-03-03 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.